Telangana Life Science Policy for Startups & MNCs
Telangana has quickly become the primary focus of the revolution in life sciences in India. Hyderabad is at the forefront of pharmaceutical and biotech product development, manufacturing, and exporting. The city supports enormous vaccine production facilities and is home to Genome Valley, India’s first biotech cluster.
The Telangana government released the Telangana Life Science Policy 2023 in order to capitalize on this momentum. Making the state one of the best life sciences ecosystems in the world is the goal of the ambitious and forward-thinking program.
This article explains the policy’s vision, main incentives, intended ecosystem, and how Cretum Advisory may facilitate stakeholders’ smooth access to these opportunities..
Policy Vision and Objectives of Telangana Life Science Policy
The Telangana Life Sciences Policy aims to:
- Make Telangana a global life sciences innovation hub
- Increase revenue above ₹64,000 crore by 2030.
- Create 4 lakh new jobs in research and development, pharmaceuticals, biotechnology, and medical technology.
- Promote excellent R&D, infrastructure, and new businesses.
- Create a strong ecosystem for clinical and regulatory research.
The Telangana Life Science Policy vision is in line with India’s national objectives to reach a life sciences sector value of $120 billion by 2030, of which Telangana will account for 35–40%.
Key Components of the Policy
1. Infrastructure Expansion
- Expansion of Genome Valley to accommodate more global biotech and pharma players
- Development of Hyderabad Pharma City – the world’s largest pharma industrial zone
- Launch of Medical Devices Park at Sultanpur
2. Skill and Talent Pipeline
Collaborations with universities, IITs, NIPER, and business organizations for the Regulatory affairs, biotech engineering, and clinical research talent are given special consideration.
Telangana’s strong intellectual property infrastructure, investor-friendly governance, and easy access to the air, road, and sea make it an unmatched commercial destination for global life science companies.
3. Startup and Innovation Support
- Grants up to ₹2 crore for eligible biotech startups
- Availability of incubators such as IKP Knowledge Park and B-Hub
- Patent support, mentorship, and international market access
4. Research and Manufacturing Incentives
- Up to 25% subsidy on R&D equipment
- Incentives on API, biosimilars, and vaccine manufacturing
- Tax incentives for businesses operating in medical parks and bulk drug parks
📍 Telangana’s Strategic Advantage
Telangana—and Hyderabad in particular—has already positioned itself as the Pharma Capital of India, accounting for:
35% of India’s pharma production
40% of total pharma exports
There are about 800 life sciences companies, including Aurobindo Pharma, Novartis, Dr. Reddy’s, Biological E, and Bharat Biotech.
Telangana’s smooth air, road, and sea connectivity, strong intellectual property infrastructure, and investor-friendly governance make it an unrivalled business environment for international life science enterprises.
Important Points & Information
| Parameter | Insight |
|---|---|
| Policy Duration | 2023–2030 |
| Investment Target | ₹64,000 crore |
| Jobs to be Created | 4 lakh+ |
| Pharma Export Share | 40% of India’s total pharma exports |
| Genome Valley Occupancy | 200+ biotech and pharma companies |
| MedTech Park Investment | ₹1500 crore+ |
| Startup Grant | Up to ₹2 crore |
| Bulk Drug Park Location | Yadadri-Bhuvanagiri District |
How Cretum Advisory Supports Life Science Businesses?
Navigating state incentives, approvals, and compliance can be a major challenge. That’s where Cretum Advisory comes in. We help startups, MNCs, research labs, and manufacturers to identify, apply, and benefit from the full scope of Telangana’s Life Sciences Policy.
Our Services Include:
- Policy Advisory & Incentive Eligibility
- Entity Setup in Genome Valley / Pharma City
- Startup Grant Filing & Patent Support
- DPR & Business Plan Preparation
- Clinical Research Compliance & Licensing
- GST, Tax & R&D Deduction Strategy
- Export Advisory for APIs & Biosimilars
- FEMA, FDI, and Foreign Pharma Compliance
- GET Financial Advisory Services for your business
Cretum makes the process easy and lawful, whether you’re growing your biotech company, setting up a facility to manufacture vaccines, or entering the Indian medical technology market.
The Final Thought
The Telangana Life Sciences Policy 2023 is a framework for transforming the state into a global leader in the life sciences, not only an incentive program. Telangana offers unparalleled benefits to anyone in the pharmaceutical, biotech, and MedTech sectors thanks to its excellent infrastructure, industry presence, expanding talent pool, and future-ready governance.
This is the ideal moment for anyone wishing to create, grow, or invest.
Frequently Asked Questions (FAQs)
Q1: Who can apply for incentives under the Telangana Life Sciences Policy?
A: R&D facilities, biotech firms, pharmaceutical manufacturers, MedTech firms, and start-ups.
Q2: Does the government own Genome Valley?
A: With cooperation between the public and commercial sectors, Telangana does support it.
Q3: What kinds of grants are accessible to biotech entrepreneurs?
A: Grants of up to ₹2 crore, including with support for incubation, IP, and market access.
Q4: Is Hyderabad Pharma City open to foreign investment?
A: With single-window approval and FDI facilitation, yes.
Q5: How can Cretum Advisory help?
A: From setup to subsidy claims to regulatory approvals, we manage it all.